Center types in Indiana
Community Hospital Program (1)
Dedicated MS Practice (1)
Filter by type:All (2)Community Hospital Program (1)Dedicated MS Practice (1)
50% of MS centers in Indiana are classified as Community Hospital Program facilities.
Centers with Most Active Trials in Indiana
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in Indiana
MS Care by City
Fort Wayne1
Merrillville1
Compare MS Centers in Indiana
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Methodist Hospitals Neuroscience Institute Merrillville | Dedicated MS Practice | ✓ | — | 3.8/5 |
| Community Hospital Program | — | — | 3.2/5 |
Active MS clinical trials in Indiana
See all 15 trials →ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Merrillville
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Indianapolis
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Indianapolis
ActivePhase 3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Avon
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Indianapolis
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Fort Wayne
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Fort Wayne
Check out the MS Buddy App
It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
